Dan M. Roden — MDRPedia
DM
Top 1% — Elite

Dan M. Roden

Pharmacogenomics

United States

146 H-Index
1,764 Total Impact

Overview

Dan M. Roden is a pharmacogenomics specialist with an H-index of 146 at Vanderbilt University (Faculty). Has been published in New England Journal of Medicine, The Lancet Oncology, Nature Biotechnology. Based in United States.

Biography

Dan Roden is a Canadian-born American medical researcher known for his work in personalized medicine. He is Professor of Medicine, Pharmacology and Biomedical Informatics at the Vanderbilt University School of Medicine, where he holds the Sam L. Clark Endowed Chair and serves at the Senior Vice President for Personalized Medicine. He is also the director of Vanderbilt University's BioVU project, which is a biobank linking individuals' DNA samples to their medical records.

Affiliations & Institutions

Vanderbilt University

Faculty

Research Impact

5 Publications
0 Total Citations

Publication Timeline

0122016201920212022

Published In

LancetClin Pharmacol TherJAMAGenet MedN Engl J Med

Key Publications

Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
N Engl J Med 2016
PubMed

Areas of Expertise

Medical Specialties

Pharmacogenomics